潘崚, 许娜. SIMPLIFY-1: 莫洛替尼对比芦可替尼的非劣效性临床试验[J]. 循证医学, 2019, 19(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2019.02.005
    引用本文: 潘崚, 许娜. SIMPLIFY-1: 莫洛替尼对比芦可替尼的非劣效性临床试验[J]. 循证医学, 2019, 19(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2019.02.005
    PAN Ling, XU Na. SIMPLIFY-1: A Noninferior Clinical Trial for Momelotinib Versus Ruxolitinib[J]. Journal of Evidence-Based Medicine, 2019, 19(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2019.02.005
    Citation: PAN Ling, XU Na. SIMPLIFY-1: A Noninferior Clinical Trial for Momelotinib Versus Ruxolitinib[J]. Journal of Evidence-Based Medicine, 2019, 19(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2019.02.005

    SIMPLIFY-1: 莫洛替尼对比芦可替尼的非劣效性临床试验

    SIMPLIFY-1: A Noninferior Clinical Trial for Momelotinib Versus Ruxolitinib

    /

    返回文章
    返回